PureTech Health annual stock-based compensation
2018
2019
2020
2021
2022
2023
2024
2025
PureTech Health Stock-Based Compensation Growth & History (PRTC)
PureTech Health's stock-based compensation was $8.2M for fiscal 2025.
View full PureTech Health company overviewPureTech Health annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.2M | −$14.6M | −64.02% |
| 2024 | 2024-12-31 | $22.9M | $18.4M | +417.55% |
| 2023 | 2023-12-31 | $4.4M | −$10.3M | −69.96% |
| 2022 | 2022-12-31 | $14.7M | $749,000 | +5.37% |
| 2021 | 2021-12-31 | $13.9M | $3.2M | +30.15% |
| 2020 | 2020-12-31 | $10.7M | −$3.8M | −25.92% |
| 2019 | 2019-12-31 | $14.5M | $1.8M | +14.49% |
| 2018 | 2018-12-31 | $12.6M | — | — |
PureTech Health stock-based compensation trends
Over the last five fiscal years, PureTech Health's stock-based compensation decreased from $10.7M to $8.2M, a change of −$2.5M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PureTech Health source filings ↗